Physician
Arkansas Valley Regional Medical Center
Arkansas Valley Regional Medical Center was paid $6.54M by Medicaid between Jan 2018 and Dec 2024, across 88 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.
33Billing provider infoARKANSAS VALLEY REGIONAL MEDICAL CENTER
LA JUNTA, CO 81050
LA JUNTA, CO 81050
33aNPI1760489470assigned 07/07/2005
33bProvider typeClinical Pathology/Laboratory Medicine Physician
28Total paid$6.54M
24GClaims159,107
24DCodes billed88
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Pathology/Laboratory Medicine Physician providers in Colorado
Rank by total paid#2 of 5
Median peer was paid$1.80M
This provider vs. median3.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,937 | $839K | |
| 2019 | 23,457 | $791K | |
| 2020 | 15,953 | $587K | |
| 2021 | 19,079 | $663K | |
| 2022 | 23,232 | $1.17M | |
| 2023 | 27,155 | $1.33M | |
| 2024incomplete | 22,294 | $1.16M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 30% | 17,559 | 14,893 | $1.97M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 19,734 | 15,040 | $1.77M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 18% | 7,757 | 6,622 | $1.15M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5.6% | 2,975 | 2,773 | $364K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.3% | 1,064 | 935 | $215K |
| 80053 | Comprehensive metabolic panel | 2.9% | 19,442 | 16,547 | $188K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.8% | 3,978 | 3,219 | $183K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.6% | 252 | 229 | $173K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.0% | 2,430 | 2,065 | $131K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 190 | 174 | $60K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 416 | 384 | $42K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 108 | 97 | $38K |
76 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 438 | $28K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,889 | $24K |
| 83880 | <1% | 2,190 | $21K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 781 | $20K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 176 | $18K |
| 59025 | Fetal non-stress test | <1% | 113 | $18K |
| 84484 | <1% | 2,479 | $14K | |
| 80320 | <1% | 193 | $12K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 122 | $11K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 476 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,144 | $11K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 60 | $6K |
| 83605 | <1% | 1,547 | $6K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,036 | $5K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 32 | $5K |
| 87040 | <1% | 316 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,106 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 20,712 | $2K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 59 | $2K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 16 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,748 | $2K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,010 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 295 | $2K |
| 73562 | <1% | 27 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $2K |
| 76801 | <1% | 12 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,899 | $1K |
| 73100 | <1% | 17 | $1K | |
| 84145 | <1% | 713 | $876.23 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 201 | $875.58 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 92 | $869.38 |
| 80061 | Lipid panel | <1% | 77 | $805.01 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 12 | $650.76 |
| G0378 | Hospital observation service, per hour | <1% | 13 | $647.54 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,212 | $540.14 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 560 | $476.39 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 34 | $361.76 |
| 85379 | <1% | 84 | $323.56 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 988 | $304.13 |
| 36000 | <1% | 630 | $275.73 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 114 | $262.02 |
| 82728 | <1% | 12 | $247.52 | |
| 73030 | <1% | 73 | $216.19 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,558 | $215.82 |
| 83721 | <1% | 14 | $143.88 | |
| 71045 | Radiologic examination, chest; single view | <1% | 346 | $125.80 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,346 | $121.71 |
| 83735 | <1% | 463 | $100.49 | |
| 76000 | <1% | 40 | $99.32 | |
| 84439 | <1% | 15 | $94.85 | |
| 83690 | <1% | 2,590 | $91.15 | |
| 82150 | <1% | 1,227 | $79.50 | |
| 83540 | <1% | 12 | $78.48 | |
| J2704 | Injection, propofol, 10 mg | <1% | 762 | $74.72 |
| 84703 | <1% | 546 | $71.66 | |
| 81001 | <1% | 3,908 | $70.36 | |
| 81003 | <1% | 2,472 | $66.31 | |
| 83550 | <1% | 12 | $65.40 | |
| 72100 | <1% | 21 | $57.88 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 969 | $31.34 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,768 | $18.23 |
| 87081 | 0% | 52 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 136 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 57 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 30 | $0.00 |
| 87077 | 0% | 29 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 17 | $0.00 |
| 82803 | 0% | 12 | $0.00 | |
| 83615 | 0% | 14 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 799 | $0.00 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 78 | $0.00 |
| 88313 | 0% | 45 | $0.00 | |
| 88312 | 0% | 75 | $0.00 | |
| 87186 | 0% | 29 | $0.00 | |
| 00731 | 0% | 13 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGEARHART, HEIDI (CNO)
| Provider | Location | Paid |
|---|---|---|
| Arkansas Valley Regional Medical Center | La Junta, CO | $1.80M |
| Arkansas Valley Regional Medical Center | La Junta, CO | $10K |
| Arkansas Valley Regional Medical Center | La Junta, CO | $704.05 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.